Avita Medical (RCEL) announced it has entered into an exclusive distribution agreement with Revolution Surgical. This agreement marks an important milestone in our expansion into the Australian and New Zealand markets. Under the terms of the agreement, Revolution Surgical will serve as the exclusive distributor of the Recell product platform, including Recell GO, in Australia and New Zealand. This partnership aims to enhance the availability and accessibility of Avita Medical’s products to a broader customer base in these regions.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter